Drug Information

Drug General Information
Drug ID
D0GP8N
Former ID
DNCL002353
Drug Name
MK-8808
Indication Late-stage follicular lymphoma [ICD9: 202.0, 202.8; ICD10:C81-C86, C82] Phase 3 [549266]
Rheumatoid arthritis [ICD9: 710-719, 714; ICD10:M05-M06] Phase 1 [549266]
Company
Merck
Target and Pathway
Target(s) B-lymphocyte antigen CD20 Target Info Agonist [526862]
KEGG Pathway Hematopoietic cell lineage
References
Ref 549266Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800034367)
Ref 526862Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance. Oncogene. 2003 Oct 20;22(47):7359-68.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.